Precision Biosciences (DTIL) Cash & Equivalents (2018 - 2025)
Historic Cash & Equivalents for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $44.9 million.
- Precision Biosciences' Cash & Equivalents fell 5456.29% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.9 million, marking a year-over-year decrease of 5456.29%. This contributed to the annual value of $85.9 million for FY2024, which is 2637.94% down from last year.
- Per Precision Biosciences' latest filing, its Cash & Equivalents stood at $44.9 million for Q3 2025, which was down 5456.29% from $62.2 million recorded in Q2 2025.
- Precision Biosciences' Cash & Equivalents' 5-year high stood at $212.1 million during Q3 2022, with a 5-year trough of $44.9 million in Q3 2025.
- Its 5-year average for Cash & Equivalents is $133.6 million, with a median of $137.8 million in 2024.
- Per our database at Business Quant, Precision Biosciences' Cash & Equivalents skyrocketed by 5998.46% in 2021 and then tumbled by 5456.29% in 2025.
- Precision Biosciences' Cash & Equivalents (Quarter) stood at $143.7 million in 2021, then skyrocketed by 31.96% to $189.6 million in 2022, then crashed by 38.45% to $116.7 million in 2023, then fell by 26.38% to $85.9 million in 2024, then tumbled by 47.76% to $44.9 million in 2025.
- Its Cash & Equivalents was $44.9 million in Q3 2025, compared to $62.2 million in Q2 2025 and $77.2 million in Q1 2025.